Observational studyArteriosclerosis, thrombosis, and vascular biology2026
Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.
Seonji Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.